Bio-Rad Laboratories PE ratio BIO
Share price divided by earnings per share over the last twelve months, since 2011.
- Today, Nov 2, 2026
- 44.4×
- 10-year median
- 30.9×
- Against its 10-year history
- 54th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 5.3× to 457×
- Peer median
- 37.0×
Bio-Rad Laboratories' PE ratio is 44.4× as of Nov 2, 2026: a share price of $366.16 against $8.25 of earnings per share over the last twelve months.
That is above its ten-year median of 30.9×, close to the middle of its last ten years.
Over that time it ranged from 5.3× in Dec 2018 to 457× in Sep 2017.
The median for 10 diagnostics and research stocks of a similar size is 37.0×.
PE ratio over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 44.4× | 10.0× | 53.6× |
| 2025 | 28.9× | 22.5× | 28.9× |
| 2024 | n/m a value too high to mean anything | ||
| 2023 | n/m a value too high to mean anything | ||
| 2022 | n/m a value too high to mean anything | ||
| 2021 | n/m a value too high to mean anything | ||
| 2020 | 10.1× | 10.1× | 33.1× |
| 2019 | 30.2× | 5.4× | 30.7× |
| 2018 | 5.4× | 5.3× | 347× |
| 2017 | 302× | 56.0× | 457× |
| 2016 | 54.7× | 34.3× | 55.1× |
| 2015 | 39.5× | 38.5× | 46.2× |
| 2014 | 44.0× | 39.4× | 57.4× |
| 2013 | 40.2× | 17.1× | 40.2× |
| 2012 | 16.4× | 14.8× | 17.9× |
| 2011 | 14.6× | 13.7× | 19.1× |
Against its peers
Companies in Medical - Diagnostics & Research nearest Bio-Rad Laboratories' size, closest first, today.
| Company | PE ratio |
|---|---|
| BIOBio-Rad Laboratories | 44.4× |
| CAICaris Life Sciences | 86.8× |
| LNTHLantheus | 24.3× |
| RVTYRevvity | 72.2× |
| MEDPMedpace | 38.0× |
| BLLNBillionToOne | 170× |
| CDNACareDx | 35.9× |
| VCYTVeracyte | 35.0× |
| DGXQuest Diagnostics | 24.9× |
| LHLabcorp | 29.4× |
| MTDMettler-Toledo International | 38.4× |
| Peer median | 37.0× |
Where Bio-Rad Laboratories ranks
What the PE ratio tells you
Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.
Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.
More on Bio-Rad Laboratories
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.